Eller, Philipp

Serum Amyloid A in Uremic HDL Promotes Inflammation

Weichhart, T., Kopecky, C., Kubicek, M., Haidinger, M., Döller, D., Katholnig, K., Suarna, C., Eller, P., Tölle, M., Gerner, C., et al. (2012) · Journal of the American Society of Nephrology

Dialysis and Renal Disease ManagementCholesterol and Lipid Metabolism

Cited by 201

Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: The DIANA study.

De Bus, L., Depuydt, P., Steen, J., Dhaese, S., De Smet, K., Tabah, A., Akova, M., Cotta, M. O., De Pascale, G., Dimopoulos, G., et al. (2020) · Intensive Care Medicine

Antibiotic Use and ResistanceNosocomial Infections in ICU

Cited by 114

Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation

Moschovaki Filippidou, F., Kirsch, A. H., Thelen, M., Kétszeri, M., Artinger, K., Aringer, I., Schabhüttl, C., Mooslechner, A. A., Frauscher, B., Pollheimer, M., et al. (2020) · The American Journal of Pathology

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 66

Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit

Reisinger, A. C., Niedrist, T., Posch, F., Hatzl, S., Hackl, G., Prattes, J., Schilcher, G., Meißl, A.-M., Raggam, R. B., Herrmann, M., et al. (2021) · Scientific Reports

Sepsis Diagnosis and TreatmentInflammation biomarkers and pathways

Cited by 19

Feasibility of Blood Glucose Management Using Intra-Arterial Glucose Monitoring in Combination with an Automated Insulin Titration Algorithm in Critically Ill Patients

Mader, J. K., Motschnig, M., Theiler-Schwetz, V., Eibel-Reisz, K., Reisinger, A. C., Lackner, B., Augustin, T., Eller, P., & Mirth, C. (2019) · Diabetes Technology & Therapeutics

Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and Research

Cited by 4